Clementia - Articles and news items

Success for Clementia’s Phase II Fibrodysplasia Ossificans Progressiva trial

Industry news / 18 October 2016 / Niamh Louise Marriott, Digital Content Producer

Palovarotene was well-tolerated, with all subjects completing the 12-week trial and enrolling into the open-label extension trial…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+